To evaluate the effects of CD10+ and CD10− fibroblasts on in vivo tumor growth, we cotransplanted CD133+ or CD133− HCT116 cancer cells and CD10+ or CD10− fibroblasts into SCID mice. This evidence concerns the gene PROM1 and neoplasm.